- Home
- PI vs CNTA Comparison
PI vs CNTA Comparison
Compare PI & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PI
- CNTA
- Stock Information
- Founded
- PI 2000
- CNTA 2020
- Country
- PI United States
- CNTA United Kingdom
- Employees
- PI N/A
- CNTA N/A
- Industry
- PI Industrial Machinery/Components
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- PI Technology
- CNTA Health Care
- Exchange
- PI Nasdaq
- CNTA Nasdaq
- Market Cap
- PI 1.9B
- CNTA 1.8B
- IPO Year
- PI 2016
- CNTA 2021
- Fundamental
- Price
- PI $100.00
- CNTA $12.30
- Analyst Decision
- PI Strong Buy
- CNTA Strong Buy
- Analyst Count
- PI 8
- CNTA 10
- Target Price
- PI $149.00
- CNTA $26.11
- AVG Volume (30 Days)
- PI 777.7K
- CNTA 617.5K
- Earning Date
- PI 04-23-2025
- CNTA 05-20-2025
- Dividend Yield
- PI N/A
- CNTA N/A
- EPS Growth
- PI N/A
- CNTA N/A
- EPS
- PI N/A
- CNTA N/A
- Revenue
- PI $363,539,000.00
- CNTA N/A
- Revenue This Year
- PI N/A
- CNTA N/A
- Revenue Next Year
- PI $26.78
- CNTA N/A
- P/E Ratio
- PI N/A
- CNTA N/A
- Revenue Growth
- PI 21.80
- CNTA N/A
- 52 Week Low
- PI $60.85
- CNTA $7.75
- 52 Week High
- PI $239.88
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- PI 65.44
- CNTA 40.97
- Support Level
- PI $94.81
- CNTA $11.88
- Resistance Level
- PI $100.22
- CNTA $14.39
- Average True Range (ATR)
- PI 4.30
- CNTA 0.79
- MACD
- PI 2.19
- CNTA -0.00
- Stochastic Oscillator
- PI 91.01
- CNTA 18.68
About PI Impinj Inc.
Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.